Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Vaishakhi Trivedi"'
Autor:
Prerana Jha, Vaishakhi Trivedi, Nandini Menon, Minit Shah, Irene A George, Rohit Mishra, Trupti Pai, Fuzail Ahmad, Venkataramanan Ramachandran, Vanita Noronha, Kumar Prabhash, Prashant Kumar
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 7, Iss 1, Pp 110-116 (2024)
Externí odkaz:
https://doaj.org/article/5ffbb472eed9486e93eefda84451a7d3
Autor:
Vaishakhi Trivedi, Vanita Noronha, Peddagangannagari Sreekanthreddy, Sanket Desai, Disha Poojary, Linu Varghese, Pooja Gowda, Ashwin Butle, Rohit Mishra, Munita Bal, Neha Mittal, Swapnil Rane, Shubhada Kane, Sandip Basu, Vijay Patil, Nandini Menon, Ajay Kumar Singh, Pankaj Chaturvedi, Pratik Chandrani, Anuradha Choughule, Vidya Veldore, Kumar Prabhash, Amit Dutt
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionThe diverse subtypes of thyroid carcinoma have distinct clinical outcomes despite a comparable spectrum of underlying genetic alterations. Beyond genetic alterations, sparse efforts have been made to characterize the microbes associated w
Externí odkaz:
https://doaj.org/article/2b890625a15a4721b1f62546059f1b37
Autor:
Prerana Jha, Vaishakhi Trivedi, Rohit Mishra, Pratik Chandrani, Radhika Venkatakrishnan, Venkataramanan Ramachandran, Minit Shah, Anuradha Choughule, Kumar Prabhash, Prashant Kumar, Vanita Noronha
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 6, Iss 3, Pp 457-460 (2023)
Externí odkaz:
https://doaj.org/article/9dbe840028c748e8a0df2eb1951836eb
Autor:
Asim Joshi, Ashwin Butle, Supriya Hait, Rohit Mishra, Vaishakhi Trivedi, Rahul Thorat, Anuradha Choughule, Vanita Noronha, Kumar Prabhash, Amit Dutt
Publikováno v:
Translational Oncology, Vol 22, Iss , Pp 101461- (2022)
Osimertinib, a third-generation EGFR tyrosine kinase inhibitor, shows significant benefit among patients with EGFR T790M mutation at disease progression. We analyzed the whole exome sequence of 48 samples obtained from 16 lung cancer patients with a
Externí odkaz:
https://doaj.org/article/2c2d1c8322a54a0a9f90f6c33fceddfd
Autor:
Akhil Kapoor, Vanita Noronha, Vijay M Patil, Amit Joshi, Nandini Menon, Anuradha Chougule, Pratik Chandrani, Vaishakhi Trivedi, Vichitra Behel, Rajiv Kumar, Abhishek Mahajan, Amit Janu, Kumar Prabhash
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 1, Pp 44-50 (2020)
Background: There is a scarcity of data to guide the management of older patients with cancer. We therefore conducted this study to compare the outcomes and toxicities in older versus younger patients with an epidermal growth factor receptor (EGFR)-p
Externí odkaz:
https://doaj.org/article/082243b7179d4bb2bbf5771afd7a7afb
Autor:
Anuradha Chougule, Priyanka Pange, Shrutika Kale, Vinita Jagtap, Kavya Nambiar, Ankita Nikam, Priyanka Tiwrekar, Vaishakhi Trivedi, Vichitra Behel, Akhil Kapoor, Nandini Menon, Vijay Patil, Vanita Noronha, Kumar Prabhash, S D Banavali
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 3, Pp 475-480 (2020)
Background: The concept of liquid biopsy as a surrogate for tumor tissue is not only restricted to blood-derived samples but also includes other malignant bodily fluids such as cerebrospinal fluid, pleural fluid, pericardial fluid, and ascites. The a
Externí odkaz:
https://doaj.org/article/36cf1a414bda4ff2a051047b66447df1
Autor:
Vanita Noronha, Nikhil Pande, Amit Joshi, Vijay Patil, Vaishakhi Trivedi, Anuradha Chougule, Amit Janu, Abhishek Mahajan, Vikas Talreja, Kumar Prabhash
Publikováno v:
South Asian Journal of Cancer, Vol 09, Iss 01, Pp 47-49 (2020)
Introduction: The treatment of lung cancer is not defined in the third-line setting and remains an unanswered question. Erlotinib is the only drug approved in the third-line setting. With the introduction of effective first- and second-line therapies
Externí odkaz:
https://doaj.org/article/dcdf789cf84e4a268be32218c291daa1
Autor:
Akhil Kapoor, Vanita Noronha, Vijay M Patil, Amit Joshi, Nandini Menon, Anuradha Chougule, Pratik Chandrani, Vaishakhi Trivedi, Vichitra Behel, Rajiv Kumar, Abhishek Mahajan, Amit Janu, Kumar Prabhash
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 2, Pp 383-385 (2020)
Externí odkaz:
https://doaj.org/article/b4410c2ba12f459baac6b85c3c1cb32b
Autor:
Vanita Noronha, Swaratika Majumdar, Amit Joshi, Vijay Patil, Vaishakhi Trivedi, Anuradha Chougule, Kumar Prabhash
Publikováno v:
South Asian Journal of Cancer, Vol 6, Iss 4, Pp 143-146 (2017)
Externí odkaz:
https://doaj.org/article/2287ad87836c4f079b42d92725c2e63e
Autor:
Asim Joshi, Anuradha Chougule, Pratik Chandrani, Vaishakhi Trivedi, Prajish Iyer, Kumar Prabhash, Amit Dutt
Publikováno v:
Canadian Journal of Biotechnology, Vol 1, Iss Special Issue, Pp 76-76 (2017)
Introduction: Lung tumors with mutations in epidermal growth factor receptor (EGFR) gene represent a clinically distinct subtype of lung cancer and are observed at a frequency of 23% among Indian patients. The standard practice for treatment of EGFR
Externí odkaz:
https://doaj.org/article/fbd095cb51c942c0a4cbe793d22ef8bd